 Substance Withdrawal Syndrome
"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Descriptor ID |
D013375
|
| MeSH Number(s) |
C25.775.835 F03.900.825
|
| Concept/Terms |
Substance Withdrawal Syndrome- Substance Withdrawal Syndrome
- Substance Withdrawal Syndromes
- Syndrome, Substance Withdrawal
- Syndromes, Substance Withdrawal
- Withdrawal Syndrome, Substance
- Withdrawal Syndromes, Substance
Withdrawal Symptoms- Withdrawal Symptoms
- Symptom, Withdrawal
- Symptoms, Withdrawal
- Withdrawal Symptom
Drug Withdrawal Symptoms- Drug Withdrawal Symptoms
- Drug Withdrawal Symptom
- Symptom, Drug Withdrawal
- Symptoms, Drug Withdrawal
- Withdrawal Symptom, Drug
- Withdrawal Symptoms, Drug
|
Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".
This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in this website by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 1 | 0 | 1 | | 1990 | 1 | 1 | 2 | | 1993 | 1 | 1 | 2 | | 1994 | 0 | 1 | 1 | | 1997 | 4 | 0 | 4 | | 1998 | 1 | 1 | 2 | | 2001 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2010 | 2 | 1 | 3 | | 2011 | 1 | 1 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 1 | 2 | 3 | | 2016 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles.
-
Yang M, Barrios J, Yan J, Zhao W, Yuan S, Dong E, Ai X. Causal roles of stress kinase JNK2 in DNA methylation and binge alcohol withdrawal-evoked behavioral deficits. Pharmacol Res. 2021 02; 164:105375.
-
Cohen SP, Baber ZB, Buvanendran A, McLean BC, Chen Y, Hooten WM, Laker SR, Wasan AD, Kennedy DJ, Sandbrink F, King SA, Fowler IM, Stojanovic MP, Hayek SM, Phillips CR. Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises. Pain Med. 2020 11 07; 21(7):1331-1346.
-
Mathew AR, Zhou M. Distress tolerance in relation to cessation history and smoking characteristics among adult daily smokers. Addict Behav. 2020 01; 100:106124.
-
Heckman BW, Dahne J, Germeroth LJ, Mathew AR, Santa Ana EJ, Saladin ME, Carpenter MJ. Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers. J Consult Clin Psychol. 2018 Nov; 86(11):903-914.
-
Gottlieb M, Gore K. Do a2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal? Ann Emerg Med. 2017 06; 69(6):740-742.
-
Herrold AA, Persons AL, Napier TC. Cellular distribution of AMPA receptor subunits and mGlu5 following acute and repeated administration of morphine or methamphetamine. J Neurochem. 2013 Aug; 126(4):503-17.
-
Mathew AR, Robinson JD, Norton PJ, Cinciripini PM, Brown RA, Blalock JA. Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine Tob Res. 2013 Nov; 15(11):1807-15.
-
Armstrong SR, Campbell CB, Richardson CL, Vickery RG, Tsuruda PR, Long DD, Hegde SS, Beattie DT. The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity. Naunyn Schmiedebergs Arch Pharmacol. 2013 Jun; 386(6):471-8.
-
Marousi S, Travasarou M, Karageorgiou CE, Gheuens S, Koralnik IJ. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 Nov 20; 79(21):2160; author reply 2160.
-
Lutgen V, Kong L, Kau KS, Madayag A, Mantsch JR, Baker DA. Time course of cocaine-induced behavioral and neurochemical plasticity. Addict Biol. 2014 Jul; 19(4):529-38.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|